Brian Andrew Cogan

Healthcare Analyst at Glenview Capital Management LLC

Brian Andrew Cogan

Brian Andrew Cogan

Healthcare Analyst at Glenview Capital Management LLC

Biography

Presently, Brian Andrew Cogan occupies the position of Healthcare Analyst at Glenview Capital Management LLC. Mr. Cogan previously occupied the position of Research Analyst at Hudson Executive Capital LP and Associate at Barclays Capital, Inc. Mr. Cogan received an undergraduate degree from Boston College.

Overview
RelSci Relationships

1631

Relationships
RelSci Relationships are individuals Brian Andrew Cogan likely has professional access to. A relationship does not necessarily indicate a personal connection.

Senior Analyst at Glenview Capital Management LLC

Relationship likelihood: Average

Senior Analyst at Glenview Capital Management LLC

Relationship likelihood: Average

Senior Analyst at Glenview Capital Management LLC

Relationship likelihood: Average

Managing Director at Glenview Capital Management LLC

Relationship likelihood: Average

Managing Director at Glenview Capital Management LLC

Relationship likelihood: Average

Analyst at Glenview Capital Management LLC

Relationship likelihood: Average

Partner at Glenview Capital Management LLC

Relationship likelihood: Average

Partner & Co-Head of Health Care at Glenview Capital Management LLC

Relationship likelihood: Average

Senior Analyst & Partner at Glenview Capital Management LLC

Relationship likelihood: Average

Partner at Glenview Capital Management LLC

Relationship likelihood: Average

Paths to Brian Andrew Cogan
Potential Connections via
Relationship Science
You
Brian Andrew Cogan
Healthcare Analyst at Glenview Capital Management LLC
Education
BS in Finance
Class of 2010

Boston College is one of the nation's best and most selective universities, with U.S. News & World Report ranking Boston College 31st among national universities, and Forbes ranking it 26th in its 2012 America's Best Colleges listing. Boston College confers more than 4,000 degrees annually in more than 50 fields of study through eight schools and colleges. Faculty members are committed to both teaching and research having earned nearly $60 million in research grants in the last year alone. The University has made a major commitment to academic excellence. As part of its Strategic Plan, Boston College is in the process of adding 100 new faculty positions, expanding faculty and graduate research, increasing student financial aid to more than $128 million annually, and widening opportunities in key undergraduate programs, such as international study, internships and student formation. Boston College has experienced tremendous growth in recent years, including a 75 percent increase in undergraduate applications over the past decade, to more than 34,000 for the 2,250 seats in its freshman class. During the same period, an increase in voluntary giving from alumni has helped to move the University's endowment to approximately $1.9 billion. Boston College students have also earned more than 200 prestigious academic scholarships over the past decade, including 2 Rhodes Scholarships, 4 Marshalls, 9 Goldwaters and 162 Fulbright grants.

Career History
Healthcare Analyst
Current

Glenview Capital Management (GCM) manages the Glenview Funds, the Opportunity Funds, the GCM Equity Funds, and the Little Arbor Funds. The Glenview Funds employ a long/short strategy that invests in equity and fixed income securities using a bottom-up, fundamental research process. The Glenview Funds have position size and gross exposure guidelines. The Opportunity Funds employ a purely opportunistic investment approach, and have no limits as to the number or size of positions, security types or industry concentration. The GCM Equity Funds employ a long-only strategy that invests in the equity securities of companies with market-cap greater than $10 billion. The GCM Equity Funds are limited life funds that are being offered to existing investors and their affiliates in the Glenview Funds and the Opportunity Funds. The GCM Equity Funds have position size and exposure guidelines and do not expect to incur leverage in order to enhance investments. GCM also manages GCM Investment Partners LP, a private fund that is open to qualified employees of GCM and certain other persons. The Fund allocates its capital to individual funds in the Glenview Fund family and the Opportunity Fund family.^GCM's investment process focuses on deep, fundamental research and individual security selection primarily within equity and credit-oriented strategies. The firm employs a GARP investment approach that focuses on companies in stable industries, with recurring revenue streams or entrenched market positions. GCM may also focus on contrarian investments (cyclical or company specific). They often combine GARP and contrarian investing when a steady growth business emerges within a company as the dominant economic force over a more challenged business unit. GCM invests in stored or hidden value situations, where excess balance sheet capacity may be used to accelerate returns or where contractual rights or startup operations show no present value but may be significant drivers of value tomorrow. ^In addition to long equity investments, GCM commits significant capital to short equity positions. They look for companies whose industries face cyclical, transitory or secular headwinds, whose competitive position is likely to erode over the near- to medium-term, and companies whose liquidity profile will potentially create equity value impairment or cause future issuance of additional equity at lower prices. GCM may also maintain short positions in equity index futures or other index products to reduce net market risk. GCM also engages in long and short credit positions with emphasis on business or asset stability over growth. GCM may seek to reduce the risk through other hedges that protect the overall portfolio of the Funds, including interest rates, foreign currencies or sovereign, corporate or asset-backed credit spreads.

Research Analyst
2015 - Prior

Hudson Executive Capital is an investment management firm formed to identify opportunities where actionable strategic and corporate finance solutions can drive returns through Constructive Engagement with managements, boards and shareholders. The Founding Partners' strategic and operational experience, corporate finance expertise and extensive network of relationships will be directed towards value-oriented investment opportunities in industry verticals representing more than 80% of the S&P 500. The Firm's Founders and portfolio management team, working alongside the Firm's CEO Partners, will leverage their industry experience in Financial Services, Healthcare, Technology/Media/Telecommunication, Consumer/Retail and General Industrials. The Firm is founded by Douglas L. Braunstein, former Vice Chairman, JPMorgan Chase & Co, and James C. Woolery, former Chairman-elect, Cadwalader, Wickersham & Taft LLP.

Analyst, Mergers & Acquisitions Group
2010 - 2014

Barclays Capital, Inc. is and SEC-registered investment advisor and broker/dealer headquartered in New York City. The firm operated through Barclays Group (US), Inc. and is ultimately owned by Barclays plc (LON: BARC). Their Global Markets team provides execution and risk management services across the full range of asset classes around the world to corporations, governments and financial institutions. They provide solutions to their clients' financing and risk management needs including: bonds, commodities, credit products, equity derivatives, inflation linked products, interest rate products, foreign exchange, leveraged finance, loans, emerging markets, prime services, private equity and securitization. Barclays provides analysis on broad themes of relevance to institutional investors, including detailed analysis of global markets and of a wide range of investment grade and high yield issuers. Research is highly quantitative in orientation, yet is presented in an accessible and concise format. The firm's research seeks to present clients with a globally integrated perspective across products and geographies, providing clients with the tools and insights necessary for successful risk management and financing.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Brian Andrew Cogan. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Brian Andrew Cogan's profile does not indicate a business or promotional relationship of any kind between RelSci and Brian Andrew Cogan.